The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
A Concise Review of Pulmonary Sarcoidosis
Open accessAbstract
This is an update on sarcoidosis, focusing on etiology, diagnosis, and treatment. In the area of etiopathogenesis, we now have a better understanding of the immune response that leads to the disease as well as genetic factors that modify both the risk for the disease and its clinical outcome. Several groups have also identified possible agents as a cause for sarcoidosis. Although none of these potential causes has been definitely confirmed, there is increasing evidence to support that one or more infectious agents may cause sarcoidosis, although this organism may no longer be viable in the patient. The diagnosis of sarcoidosis has been significantly aided by new technology. This includes the endobronchial ultrasound, which has been shown to increase the yield of needle aspiration of mediastinal and hilar lymph nodes. The positive emission tomography scan has proven useful for selecting possible biopsy sites by identifying organ involvement not appreciated by routine methodology. It has also helped in assessing cardiac involvement. The biologic agents, such as the anti-tumor necrosis factor antibodies, have changed the approach to refractory sarcoidosis. There is increasing evidence that the clinician can identify which patient is most likely to benefit from such therapy. As new and more potent antiinflammatory agents have been developed, it is clear that there are other factors that burden the patient with sarcoidosis, including fatigue and sarcoidosis-associated pulmonary hypertension. There have been several recent studies demonstrating treatment options for these problems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis
BAUGHMAN, R. P., TEIRSTEIN, A. S., JUDSON, M. A., ROSSMAN, M. D., YEAGER, H., BRESNITZ, E. A., DePALO, L., HUNNINGHAKE, G., IANNUZZI, M. C., JOHNS, C. J., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104046 · Cited by 1,808
Self-citationHunninghake, G. W., Costabel, U., Ando, M., Baughman, R. P., Cordier, J. F., du Bois, R. M., Eklúnd, A., Kitaichi, M., Lynch, J. P., Rizzato, G., et al. (1999) · PubMed · Cited by 1,324
Self-citationGrading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.
Silverman, K. J., Hutchins, G. M., & Bulkley, B. H. (1978) · Circulation · doi:10.1161/01.cir.58.6.1204 · Cited by 984
ATS/ERS/WASOG statement on sarcoidosis
Costabel, U., Hunninghake, G. W., & on behalf of the Sarcoidosis Statement Committee (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d02.x · Cited by 862
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Baughman, R. P., Drent, M., Kavuru, M., Judson, M. A., Costabel, U., du Bois, R., Albera, C., Brutsche, M., Davis, G., Donohue, J. F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-402oc · Cited by 714
Self-citationPrognosis of Intrathoracic Sarcoidosis in England
Scadding, J. G. (1961) · BMJ · doi:10.1136/bmj.2.5261.1165 · Cited by 638
Herbort, C. P., Rao, N. A., Mochizuki, M., & Commi, T. M. O. T. S. (2009) · Ocular Immunology and Inflammation · doi:10.1080/09273940902818861 · Cited by 542
Sarcoidosis is associated with a truncating splice site mutation in BTNL2
Valentonyte, R., Hampe, J., Huse, K., Rosenstiel, P., Albrecht, M., Stenzel, A., Nagy, M., Gaede, K. I., Franke, A., Haesler, R., et al. (2005) · Nature Genetics · doi:10.1038/ng1519 · Cited by 491
Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies
Uemura, A., Morimoto, S.-I., Hiramitsu, S., Kato, Y., Ito, T., & Hishida, H. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70115-8 · Cited by 487
Eishi, Y., Suga, M., Ishige, I., Kobayashi, D., Yamada, T., Takemura, T., Takizawa, T., Koike, M., Kudoh, S., Costabel, U., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.1.198-204.2002 · Cited by 442
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis
Nunes, H. (2005) · Thorax · doi:10.1136/thx.2005.042838 · Cited by 420
Cardiac Involvement in Patients with Sarcoidosis
Mehta, D., Lubitz, S. A., Frankel, Z., Wisnivesky, J. P., Einstein, A. J., Goldman, M., Machac, J., & Teirstein, A. (2008) · Chest · doi:10.1378/chest.07-2784 · Cited by 398
HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites
Rossman, M. D., Thompson, B., Frederick, M., Maliarik, M., Iannuzzi, M. C., Rybicki, B. A., Pandey, J. P., Newman, L. S., Magira, E., Beznik-Cizman, B., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/378097 · Cited by 387
Song, Z., Marzilli, L., Greenlee, B. M., Chen, E. S., Silver, R. F., Askin, F. B., Teirstein, A. S., Zhang, Y., Cotter, R. J., & Moller, D. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040429 · Cited by 372
Morgan, S. L., Baggott, J. E., Vaughn, W. H., Austin, J. S., Veitch, T. A., Lee, J. Y., Koopman, W. J., Krumdieck, C. L., & Alarcon, G. S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00002 · Cited by 360
British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.
Gibson, G. J., Prescott, R. J., Muers, M. F., Middleton, W. G., Mitchell, D. N., Connolly, C. K., & Harrison, B. D. (1996) · Thorax · doi:10.1136/thx.51.3.238 · Cited by 348
Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.
Baughman, R. P., Winget, D., & Lower, E. E. (2000) · PubMed · Cited by 344
Self-citationTremblay, A., Stather, D. R., MacEachern, P., Khalil, M., & Field, S. K. (2009) · Chest · doi:10.1378/chest.08-2768 · Cited by 332
Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis
Moller, D. R., Forman, J. D., Liu, M. C., Noble, P. W., Greenlee, B. M., Vyas, P., Holden, D. A., Forrester, J. M., Lazarus, A., Wysocka, M., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4952 · Cited by 329
Teirstein, A. S., Machac, J., Almeida, O., Lu, P., Padilla, M. L., & Iannuzzi, M. C. (2007) · Chest · doi:10.1378/chest.07-1178 · Cited by 329
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
Judson, M. A., Baughman, R. P., Costabel, U., Flavin, S., Lo, K. H., Kavuru, M. S., Drent, M., & the Centocor T48 Sarcoidosis investigators (2008) · European Respiratory Journal · doi:10.1183/09031936.00051907 · Cited by 324
Self-citationGottlieb, J. E., Israel, H. L., Steiner, R. M., Triolo, J., & Patrick, H. (1997) · Chest · doi:10.1378/chest.111.3.623 · Cited by 310
The Clinical Management of Sarcoidosis A 50-Year Experience at the Johns Hopkins Hospital
Johns, C. J., & Michele, T. M. (1999) · Medicine · doi:10.1097/00005792-199903000-00001 · Cited by 310
Connective Tissue Disease-Associated Interstitial Lung Disease
Fischer, A., West, S. G., Swigris, J. J., Brown, K. K., & du Bois, R. M. (2010) · Chest · doi:10.1378/chest.10-0194 · Cited by 303
Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics: Table. 1—
Shorr, A. F., Helman, D. L., Davies, D. B., & Nathan, S. D. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00083404 · Cited by 290
Judson, M. A., Baughman, R. P., Teirstein, A. S., Ml, T., & Yeager, H. (1999) · PubMed · Cited by 284
Self-citationIncidence of Pulmonary Hypertension and Its Clinical Relevance in Patients With Sarcoidosis
Handa, T., Nagai, S., Miki, S., Fushimi, Y., Ohta, K., Mishima, M., & Izumi, T. (2006) · Chest · doi:10.1378/chest.129.5.1246 · Cited by 270
Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis
Hofmann, S., Franke, A., Fischer, A., Jacobs, G., Nothnagel, M., Gaede, K. I., Schürmann, M., Müller-Quernheim, J., Krawczak, M., Rosenstiel, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.198 · Cited by 269
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen
Muller-Quernheim, J., Kienast, K., Held, M., Pfeifer, S., & Costabel, U. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.14511179 · Cited by 244
Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2
Chen, E. S., Song, Z., Willett, M. H., Heine, S., Yung, R. C., Liu, M. C., Groshong, S. D., Zhang, Y., Tuder, R. M., & Moller, D. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0696oc · Cited by 243
Löfgren's Syndrome: Human Leukocyte Antigen Strongly Influences the Disease Course
Grunewald, J., & Eklund, A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1082oc · Cited by 234
Survival in Sarcoidosis-Associated Pulmonary Hypertension
Baughman, R. P., Engel, P. J., Taylor, L., & Lower, E. E. (2010) · Chest · doi:10.1378/chest.09-2002 · Cited by 234
Self-citationThe Diagnostic Pathway to Sarcoidosis*
Judson, M. A., Thompson, B. W., Rabin, D. L., Steimel, J., Knattereud, G. L., Lackland, D. T., Rose, C., Rand, C. S., Baughman, R. P., & Teirstein, A. S. (2003) · Chest · doi:10.1378/chest.123.2.406 · Cited by 223
Self-citationThe BTNL2 Gene and Sarcoidosis Susceptibility in African Americans and Whites
Rybicki, B. A., Walewski, J. L., Maliarik, M. J., Kian, H., & Iannuzzi, M. C. (2005) · The American Journal of Human Genetics · doi:10.1086/444435 · Cited by 222
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
Ziegenhagen, M. W., Rothe, M. E., Schlaak, M., & Müller-Quernheim, J. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00010403 · Cited by 218
Two year prognosis of sarcoidosis: the ACCESS experience.
Judson, M. A., Baughman, R. P., Thompson, B. W., Teirstein, A. S., Ml, T., Rossman, Yeager, H., McLennan, G., Bresnitz, E. A., DePalo, L., et al. (2003) · PubMed · Cited by 211
Self-citationBaughman, R. P., Costabel, U., & du Bois, R. M. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.012 · Cited by 206
Self-citationSix-Minute Walk Test and Health Status Assessment in Sarcoidosis
Baughman, R. P., Sparkman, B. K., & Lower, E. E. (2007) · Chest · doi:10.1378/chest.06-2822 · Cited by 203
Self-citationCorticosteroids for pulmonary sarcoidosis
Paramothayan, N. S., Lasserson, T. J., & Jones, P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001114.pub2 · Cited by 198
HLA-DQB1*0201: A Marker for Good Prognosis in British and Dutch Patients with Sarcoidosis
Sato, H., Grutters, J. C., Pantelidis, P., Mizzon, A. N., Ahmad, T., van Houte, A.-J., Lammers, J.-W. J., van den Bosch, J. M. M., Welsh, K. I., & du Bois, R. M. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.4782 · Cited by 180
Judson, M. A. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.009 · Cited by 177
Self-citationChen, E. S., Wahlström, J., Song, Z., Willett, M. H., Wikén, M., Yung, R. C., West, E. E., McDyer, J. F., Zhang, Y., Eklund, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8784 · Cited by 177
Rothkrantz-Kos, S., van Dieijen-Visser, M. P., Mulder, P. G. H., & Drent, M. (2003) · Clinical Chemistry · doi:10.1373/49.9.1510 · Cited by 172
Nunes, H., Brillet, P.-Y., Valeyre, D., Brauner, M., & Wells, A. (2007) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2007-970336 · Cited by 171
Calabrese, L. H., Kirchner, E., & Shrestha, R. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.03.007 · Cited by 167
Rossman, M. D., Newman, L. S., Baughman, R. P., Teirstein, A. S., Weinberger, S. E., Miller, W. T., & Sands, B. E. (2006) · PubMed · Cited by 166
Self-citationSilverstein, E., Pertschuk, L. P., & Friedland, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6646 · Cited by 166
Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis.
Baughman, R. P., Strohofer, S., Buchsbaum, J., & Lower, E. E. (1990) · PubMed · Cited by 165
Self-citationCrouser, E. D., Culver, D. A., Knox, K. S., JULIAN, M. W., Shao, G., Abraham, S., Liyanarachchi, S., Macre, J. E., Wewers, M. D., Gavrilin, M. A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-490oc · Cited by 162
Self-citationTreatment of Sarcoidosis-Associated Pulmonary Hypertension
Barnett, C. F., Bonura, E. J., Nathan, S. D., Ahmad, S., Shlobin, O. A., Osei, K., Zaiman, A. L., Hassoun, P. M., Moller, D. R., Barnett, S. D., et al. (2009) · Chest · doi:10.1378/chest.08-1881 · Cited by 161
Cellular Recognition of Mycobacterium tuberculosis ESAT-6 and KatG Peptides in Systemic Sarcoidosis
Drake, W. P., Dhason, M. S., Nadaf, M., Shepherd, B. E., Vadivelu, S., Hajizadeh, R., Newman, L. S., & Kalams, S. A. (2007) · Infection and Immunity · doi:10.1128/iai.00732-06 · Cited by 161
Clinical predictors of pulmonary hypertension in sarcoidosis
Bourbonnais, J. M., & Samavati, L. (2008) · European Respiratory Journal · doi:10.1183/09031936.00175907 · Cited by 160
Smedema, J., Snoep, G., van Kroonenburgh, M. J. P. G., van Geuns, R., Dassen, W. R. M., Gorgels, A. P. M., & Crijns, H. J. G. M. (2005) · CHEST Journal · doi:10.1378/chest.128.1.30 · Cited by 156
Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients
Grünewald, J., Brynedal, B., Darlington, P., Nisell, M., Cederlund, K., Hillert, J. A., & Eklúnd, A. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-25 · Cited by 152
Everyday Cognitive Failure in Sarcoidosis: The Prevalence and the Effect of Anti-TNF-α Treatment
Elfferich, M., Nelemans, P. J., Ponds, R., Vries, J. D., Wijnen, P. A. H. M., & Drent, M. (2010) · Respiration · doi:10.1159/000314225 · Cited by 148
Stagaki, E., Mountford, W. K., Lackland, D. T., & Judson, M. A. (2008) · CHEST Journal · doi:10.1378/chest.08-1347 · Cited by 144
Self-citationTreatment of CNS sarcoidosis with infliximab and mycophenolate mofetil
Moravan, M. J., & Segal, B. M. (2009) · Neurology · doi:10.1212/01.wnl.0000341278.26993.22 · Cited by 142
Pulmonary Hypertension in Sarcoidosis
Baughman, R. P., Engel, P. J., & Nathan, S. D. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.08.011 · Cited by 137
Self-citationTaflin, C., Miyara, M., Nochy, D., Valeyre, D., Naccache, J., Altare, F., Peyron, P., Badoual, C., Bruneval, P., Haroche, J., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080580 · Cited by 131
Polymorphism in the Angiotensin-Converting Enzyme (ACE) Gene and Sarcoidosis
Tomita, H., 伊奈, 康., Sugiura, Y., Sato, S., Kawaguchi, H., Morishita, M., Yamamoto, M., & Ueda, R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9612011 · Cited by 118
Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy
Baughman, R. P., Shipley, R. T., Desai, S. R., Drent, M., Judson, M. A., Costabel, U., du Bois, R. M., Kavuru, M. S., Schlenker‐Herceg, R., Flavin, S. K., et al. (2009) · CHEST Journal · doi:10.1378/chest.08-1876 · Cited by 116
Self-citationInhaled iloprost for sarcoidosis associated pulmonary hypertension.
Baughman, R. P., Judson, M. A., Lower, E. E., Highland, K. B., Kwon, S. W., Craft, N., & Engel, P. J. (2009) · PubMed · Cited by 115
Self-citationFatigue in sarcoidosis: a systematic review
de Kleijn, W. P. E., Vries, J. D., Lower, E. E., Elfferich, M., Baughman, R. P., & Drent, M. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32832d0403 · Cited by 112
Self-citationMycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis
Kouba, D. J., Mimouni, D., Rencic, A., & Nousari, H. C. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05042.x · Cited by 110
Genome-wide search for sarcoidosis susceptibility genes in African Americans
Iannuzzi, M. C., Iyengar, S. K., Gray‐McGuire, C., Elston, R. C., Baughman, R. P., Donohue, J. F., Hirst, K., Judson, M. A., Kavuru, M. S., MALIARIK, M. J., et al. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364235 · Cited by 109
Self-citationMcKinzie, B. P., Bullington, W., Mazur, J. E., & Judson, M. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181b97635 · Cited by 109
Self-citationLower, E. E., Harman, S., & Baughman, R. P. (2008) · CHEST Journal · doi:10.1378/chest.07-2952 · Cited by 109
Self-citationClosure Operators and Lattice Extensions
Nation, J. B. (2004) · Order · doi:10.1007/s11083-004-5178-y · Cited by 100
Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis
Ho, L., Urban, B. C., THICKETT, D. R., Davies, R. J. O., & McMichael, A. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74231-8 · Cited by 100
Hypothesis: Sarcoidosis is a STAT1-mediated disease
Rosenbaum, J. T., Pasadhika, S., Crouser, E. D., Choi, D., Harrington, C. A., Lewis, J. A., Austin, C. R., Diebel, T. N., Vance, E. E., Braziel, R. M., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.04.010 · Cited by 96
Pulmonary and psychosocial findings at enrollment in the ACCESS study.
Yeager, H., Rossman, M. D., Baughman, R. P., Teirstein, A. S., Judson, M. A., Rabin, D. L., Iannuzzi, M. C., Rose, C. S., Bresnitz, E. A., DePalo, L., et al. (2005) · PubMed · Cited by 94
Self-citationInhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them.
Baughman, R. P., Lower, E. E., & Drent, M. (2008) · PubMed · Cited by 91
Self-citationInfliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis
Sodhi, M., Pearson, K. S., White, E. S., & Culver, D. A. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.08.016 · Cited by 91
Self-citationImmunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
Paramothayan, N. S., Lasserson, T. J., & Walters, E. H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003536.pub2 · Cited by 84
Markers of Inflammation in Sarcoidosis: Blood, Urine, BAL, Sputum, and Exhaled Gas
Bargagli, E., Mazzi, A., & Rottoli, P. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.004 · Cited by 83
The Major Histocompatibility Complex Gene Region and Sarcoidosis Susceptibility in African Americans
Rybicki, B. A., MALIARIK, M. J., Poisson, L., Sheffer, R., Chen, K. M., Major, M. L., Chase, G. A., & Iannuzzi, M. C. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112060 · Cited by 82
Pietinalho, A., Furuya, K., Yamaguchi, E., Kawakami, Y., & Selroos, O. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13d04.x · Cited by 81
Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil
Moudgil, A., Przygodzki, R. M., & Kher, K. K. (2005) · Pediatric Nephrology · doi:10.1007/s00467-005-2086-3 · Cited by 75
Gvozdenović, B., Mihailović-Vučinić, V., Dudvarski-Ilić, A., Žugić, V., & Judson, M. A. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.05.001 · Cited by 75
Self-citationChitotriosidase and soluble IL‐2 receptor: Comparison of two markers of sarcoidosis severity
Bargagli, E., Bianchi, N., Margollicci, M. A., Olivieri, C., Luddi, A., Coviello, G., Grosso, S., & Rottoli, P. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701854975 · Cited by 73
State of the Art. Potential Etiologic Agents in Sarcoidosis
Möller, D. R. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200608-155ms · Cited by 70
Pulmonary Hypertension Caused by Sarcoidosis
Diaz‐Guzman, E., Farver, C. F., Parambil, J. G., & Culver, D. A. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.010 · Cited by 67
Self-citationPietinalho, A., Ohmichi, M., Löfroos, A. B., Hiraga, Y., & Selroos, O. (2000) · PubMed · Cited by 66
Mycobacterium tuberculosis Antigen 85A Induces Th-1 Immune Responses in Systemic Sarcoidosis
Hajizadeh, R., Sato, H., Carlisle, J., Nadaf, M. T., Evans, W., Shepherd, B. E., Miller, R. F., Kalams, S. A., & Drake, W. P. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9080-4 · Cited by 65
Schramel, F. M. N. H., Golding, R. P., Haakman, C., Sutedja, T. G., de Jong, K., & Postmus, P. E. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09030406 · Cited by 58
Loddenkemper, R., Kloppenborg, A., Schoenfeld, N., Grosser, H., & Costabel, U. (1998) · PubMed · Cited by 55
C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis.
Sweiss, N., Barnathan, E. S., Lo, K. H., Judson, M. A., & Baughman, R. P. (2010) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 54
Self-citationAssessing Pulmonary Disease and Response to Therapy: Which Test?
Keir, G. J., & Wells, A. U. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0030-1262209 · Cited by 53
The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis
Judson, M. A., Gilbert, G. E., Rodgers, J. K., Greer, C. F., & Schabel, S. I. (2008) · Respirology · doi:10.1111/j.1440-1843.2007.01206.x · Cited by 47
Self-citationImmunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
Paramothayan, S., Lasserson, T., & Walters, E. H. (2001) · doi:10.1002/14651858.cd003536 · Cited by 29
Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features
Braun, J.-J., Impériale, A., Riehm, S., & Veillon, F. (2009) · Journal of Neuroradiology · doi:10.1016/j.neurad.2009.09.001 · Cited by 24
A Genome-Wide Linkage Analysis in 181 German Sarcoidosis Families Using Clustered Biallelic Markers
Fischer, A., Nothnagel, M., Schürmann, M., Müller–Quernheim, J., Schreiber, S., & Hofmann, S. (2010) · CHEST Journal · doi:10.1378/chest.09-2526 · Cited by 22
Granulomatous pneumonitis following bone marrow transplantation
Sundar, K., Carveth, H., Gosselin, M. V., Beatty, P., Colby, T. V., & Hoidal, J. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703192 · Cited by 21
Immunological marker patterns in granulomatous lymph node lesions
Brincker, H., & Pedersen, N. T. (1989) · Histopathology · doi:10.1111/j.1365-2559.1989.tb01609.x · Cited by 13
Cited by
Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.-Y., & Müller-Quernheim, J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60680-7 · Cited by 1,087
Cottin, V., Hirani, N. A., Hotchkin, D. L., Nambiar, A. M., Ogura, T., Otaola, M., Skowasch, D., Park, J. S., Poonyagariyagorn, H. K., Wuyts, W., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0076-2018 · Cited by 652
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis ― Digest Version ―
Terasaki, F., Azuma, A., Anzai, T., Ishizaka, N., Ishida, Y., Isobe, M., Inomata, T., Ishibashi-Ueda, H., Eishi, Y., Kitakaze, M., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0508 · Cited by 479
Koźmiński, P., Halik, P. K., Chesori, R., & Gniazdowska, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103483 · Cited by 326
Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis
Ungprasert, P., Ryu, J. H., & Matteson, E. L. (2019) · Mayo Clinic Proceedings: Innovations, Quality & Outcomes · doi:10.1016/j.mayocpiqo.2019.04.006 · Cited by 297
Metadata
- Authors
- Baughman, R. P., Culver, D. A., & Judson, M. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-01
- Volume
- 183
- Issue
- 5
- Pages
- 573-581
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2074372507
- Cited by
- 536
- References
- 95
- FWCI
- 16.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.